Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Significant main effects of treatment group (prior to BenjaminiHochberg correction since none were significant after correction, although the necessity of correction for multiple comparisons in exploratory analyses remains unresolved 49 ) were observed for the unclassified group and ten classified genera, namely, Acetatifactor , Akkermansia , Erysipelatoclostridium , [ Eubacterium ] coprostanoligenes group , Family XIII UCG-001 , Lactobacillus , Parasutterella , Ruminiclostridium 6 , Ruminococcaceae UCG-004 , and Ruminococcaceae UCG-009
20 mg total peptide per vial (10 mg + 10 mg) Purity: 99% (HPLC verified, each component) Container: sealed glass vial (lyophilized powder) Certificate of Analysis: lot-specific COA available, with separate purity and identity verification for both component peptides See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
When administered by experienced professionals
Refrigerate immediately at 2 to 8 degrees Celsius
Establishment of a novel autoimmune experimental model of bladder pain syndrome/interstitial cystitis in C57BL/6 mice
US$ 20.31
US$ 23.63
US$ 20.84
US$ 22.74
US$ 22.78
US$ 29.64
US$ 21.80
US$ 27.94
US$ 21.12
US$ 29.41
US$ 22.87
US$ 22.92
